Could African and Low- and Middle-Income Countries Contribute Scientifically to Global Cancer Care?
作者信息
Elzawawy Ahmed M
机构信息
Suez Canal University, Suez Canal region, Ismailia City, Egypt.
出版信息
J Glob Oncol. 2015 Nov 12;1(2):49-53. doi: 10.1200/JGO.2015.001032. eCollection 2015 Dec.
Abstract
摘要
相似文献
1
Could African and Low- and Middle-Income Countries Contribute Scientifically to Global Cancer Care?非洲以及低收入和中等收入国家能在科学上为全球癌症护理做出贡献吗？
J Glob Oncol. 2015 Nov 12;1(2):49-53. doi: 10.1200/JGO.2015.001032. eCollection 2015 Dec.
2
Could African and Low- and Middle-Income Countries Contribute Scientifically to Global Cancer Care? The Answer Is Yes!非洲以及低收入和中等收入国家能在科学上为全球癌症护理做出贡献吗？答案是肯定的！
J Glob Oncol. 2016 Mar 9;2(2):97-98. doi: 10.1200/JGO.2016.003244. eCollection 2016 Apr.
3
Optimisation of the continuum of supportive and palliative care for patients with breast cancer in low-income and middle-income countries: executive summary of the Breast Health Global Initiative, 2014.优化中低收入国家乳腺癌患者支持性和姑息治疗的连续性：2014 年乳腺健康全球倡议执行摘要。
Lancet Oncol. 2015 Mar;16(3):e137-47. doi: 10.1016/S1470-2045(14)70457-7.
4
The income-climate trap of health development: a comparative analysis of African and Non-African countries.健康发展的收入-气候陷阱：非洲国家与非非洲国家的比较分析
Soc Sci Med. 2009 Oct;69(7):1099-106. doi: 10.1016/j.socscimed.2009.07.016. Epub 2009 Aug 8.
5
Ethical considerations for designing GBS maternal vaccine efficacy trials in low-middle income countries.在低收入和中等收入国家设计GBS孕产妇疫苗效力试验的伦理考量
Vaccine. 2015 Nov 25;33(47):6396-400. doi: 10.1016/j.vaccine.2015.07.108. Epub 2015 Aug 11.
6
Role of radiotherapy in cancer control in low-income and middle-income countries.放疗在低收入和中等收入国家癌症控制中的作用。
Lancet Oncol. 2006 Jul;7(7):584-95. doi: 10.1016/S1470-2045(06)70759-8.
7
Prevalence of chronic pain in low-income and middle-income countries: a systematic review and meta-analysis.中低收入国家慢性疼痛的患病率：系统评价和荟萃分析。
Lancet. 2015 Apr 27;385 Suppl 2:S10. doi: 10.1016/S0140-6736(15)60805-4. Epub 2015 Apr 26.
8
Global Disparities of Hypertension Prevalence and Control: A Systematic Analysis of Population-Based Studies From 90 Countries.高血压患病率与控制情况的全球差异：来自90个国家基于人群研究的系统分析
Circulation. 2016 Aug 9;134(6):441-50. doi: 10.1161/CIRCULATIONAHA.115.018912.
9
Expansion of cancer care and control in countries of low and middle income: a call to action.在中低收入国家扩大癌症的防治工作：行动呼吁。
Lancet. 2010 Oct 2;376(9747):1186-93. doi: 10.1016/S0140-6736(10)61152-X. Epub 2010 Aug 13.
10
Paediatric cancer in low-income and middle-income countries.低收入和中等收入国家的儿科癌症。
Lancet Oncol. 2013 Mar;14(3):e104-16. doi: 10.1016/S1470-2045(13)70008-1. Epub 2013 Feb 20.
引用本文的文献
1
Cancer in sub-Saharan Africa: a Lancet Oncology Commission.撒哈拉以南非洲的癌症：柳叶刀肿瘤学委员会报告
Lancet Oncol. 2022 Jun;23(6):e251-e312. doi: 10.1016/S1470-2045(21)00720-8. Epub 2022 May 9.
2
Information Technology-Assisted Treatment Planning and Performance Assessment for Severe Thalassemia Care in Low- and Middle-Income Countries: Observational Study.信息技术辅助的低收入和中等收入国家重型地中海贫血治疗规划与绩效评估：观察性研究
JMIR Med Inform. 2019 Jan 23;7(1):e9291. doi: 10.2196/medinform.9291.
3
Disparities in Breast, Lung, and Cervical Cancer Trials Worldwide.全球乳腺癌、肺癌和宫颈癌试验的差异。
J Glob Oncol. 2018 Sep;4:1-11. doi: 10.1200/JGO.17.00226.
4
Investigating the Two-Tiered System of Psychosocial Cancer Care in Brazil Using a Distress Screening Measure.使用痛苦筛查措施调查巴西心理社会癌症护理的双层体系。
J Glob Oncol. 2016 Jul 20;3(1):1-6. doi: 10.1200/JGO.2016.004978. eCollection 2017 Feb.
5
Minding the Gaps in Cancer Pain Management Education: A Multicenter Study of Clinical Residents and Fellows in a Low- Versus High-Resource Setting.关注癌症疼痛管理教育中的差距：低资源与高资源环境下临床住院医师和研究员的多中心研究
J Glob Oncol. 2016 Mar 23;2(6):387-396. doi: 10.1200/JGO.2015.003004. eCollection 2016 Dec.
6
Could African and Low- and Middle-Income Countries Contribute Scientifically to Global Cancer Care? The Answer Is Yes!非洲以及低收入和中等收入国家能在科学上为全球癌症护理做出贡献吗？答案是肯定的！
J Glob Oncol. 2016 Mar 9;2(2):97-98. doi: 10.1200/JGO.2016.003244. eCollection 2016 Apr.
7
The Landscape of Randomised Controlled Trials of Therapies in Breast Cancer in Low and Middle Income Countries.低收入和中等收入国家乳腺癌治疗随机对照试验的概况
Int J Breast Cancer. 2017;2017:4259704. doi: 10.1155/2017/4259704. Epub 2017 Apr 9.
本文引用的文献
1
Medical resource utilization for administration of trastuzumab in a New Zealand oncology outpatient setting: a time and motion study.新西兰肿瘤门诊环境中曲妥珠单抗给药的医疗资源利用：一项时间与动作研究。
Clinicoecon Outcomes Res. 2015 Jul 29;7:423-30. doi: 10.2147/CEOR.S85599. eCollection 2015.
2
American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options.美国临床肿瘤学会声明：评估癌症治疗方案价值的概念框架。
J Clin Oncol. 2015 Aug 10;33(23):2563-77. doi: 10.1200/JCO.2015.61.6706. Epub 2015 Jun 22.
3
A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS).一种标准化、通用且经过验证的方法，用于对预期从抗癌治疗中获得的临床获益程度进行分层：欧洲肿瘤内科学会临床获益程度量表（ESMO-MCBS）。
Ann Oncol. 2015 Aug;26(8):1547-73. doi: 10.1093/annonc/mdv249. Epub 2015 May 30.
4
Affordable cancer care: pipedream or achievable reality?
Lancet Oncol. 2014 Mar;15(3):257-8. doi: 10.1016/S1470-2045(14)70062-2. Epub 2014 Feb 14.
5
Variation in the availability of cancer drug generics in the United States of America.美国癌症药物仿制药供应情况的差异。
Ann Oncol. 2013 Sep;24 Suppl 5:v17-22. doi: 10.1093/annonc/mdt324.
6
Has the time come for metronomics in low-income and middle-income countries?在中低收入国家，采用节拍化疗的时机是否已经成熟？
Lancet Oncol. 2013 May;14(6):e239-48. doi: 10.1016/S1470-2045(13)70056-1.
7
What is value in health care?医疗保健中的价值是什么？
N Engl J Med. 2010 Dec 23;363(26):2477-81. doi: 10.1056/NEJMp1011024. Epub 2010 Dec 8.
8
Breast Cancer Systemic Therapy: The Need for More Economically Sustainable Scientific Strategies in the World.乳腺癌全身治疗：全球对更具经济可持续性的科学策略的需求。
Breast Care (Basel). 2008;3(6):434-438. doi: 10.1159/000170233. Epub 2008 Nov 25.
9
The end of the quality improvement movement: long live improving value.质量改进运动的终结：提升价值万岁。
JAMA. 2010 Oct 27;304(16):1831-2. doi: 10.1001/jama.2010.1555.
10
Delay in seeking medical advice and late presentation of female breast cancer patients in most of the world. Could we make changes? The experience of 23 years in port said, egypt.世界上大多数地区的女性乳腺癌患者在寻求医疗建议方面存在延误和就诊较晚的情况。我们能否做出改变？以埃及塞得港的 23 年经验为例。
Breast Care (Basel). 2008 Mar;3(1):37-41. doi: 10.1159/000113936.
Zotero 插件